Investing Profile

Aaron Royston

InvestorVC

Managing Partner at venBio Partners

venbio.com/aaron.htmlSan Francisco Bay Area
Photo of Aaron Royston, Managing Partner at venBio

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
venBio Managing Partner
$20.0M - $30.0M
$25.0M
11
CompanyStageDateRound SizeTotal Raised
Ablaze Pharmaceuticals
Series ANov 2021$75M
$75M
HistoWiz
Series AOct 2021$32M
$32M
Co-investors: Jon Oringer (Pareto Holdings)
INBRACE
Series DSep 2021$100M
Series COct 2019$45M
$150M
Co-investors: Peter Moldt (Novo Ventures), Joseph Siletto (Vivo Capital)
Neurogastrx
Series BAug 2021$60M
Series AJan 2018$45M
$110M
Co-investors: Klaus Veitinger (OrbiMed), David Allison (5am Ventures)
Ventyx Biosciences
Series AMar 2021$110M
$110M
Co-investors: Richard Gaster (venBio)
RayzeBio
Series BDec 2020$110M
Series AOct 2020$45M
$150M
Co-investors: Bong Koh (Venrock)
Akero Therapeutics
Series AJun 2018$65M
$65M
Co-investors: Kevin Bitterman (Atlas Venture)
VYNE Therapeutics
Series CJul 2017$51M
$51M